Literature DB >> 19100568

Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.

Kent Kanao1, Ryuichi Mizuno, Eiji Kikuchi, Akira Miyajima, Ken Nakagawa, Takashi Ohigashi, Jun Nakashima, Mototsugu Oya.   

Abstract

PURPOSE: Recently several prognostic nomograms have been developed to predict the prognosis of malignant diseases, including renal cell carcinoma. However, to our knowledge a preoperative prognostic nomogram that predicts survival in patients with renal cell carcinoma is not available. We developed a preoperative nomogram based on the TNM classification that predicts cause specific survival in patients with renal cell carcinoma.
MATERIALS AND METHODS: A total of 545 patients with renal cell carcinoma, including metastatic disease, who underwent radical nephrectomy or nephron sparing surgery at our institution were included in the study. Cases were staged according to the 2002 UICC TNM system, 6th edition. T, N and M factors were used as prognostic factors and a Cox proportional hazards regression model was developed to predict cause specific survival. A nomogram to predict cause specific survival was developed by repeating the analysis on 200 bootstrap samples. To validate the nomogram a concordance index was estimated and calibration was also examined by plotting the predictions made by the nomogram.
RESULTS: Overall 1, 3 and 5-year patient survival was 95.2%, 92.0% and 89.9%, respectively. T, N and M factors were significant prognostic factors in the Cox proportional hazards regression model. Using the combined TNM factors we developed a nomogram predicting 1, 3 and 5-year cause specific survival rates. The nomogram had excellent ability to discriminate, as evidenced by a concordance index of 0.81, and it was generally well calibrated.
CONCLUSIONS: The preoperative information shown by this nomogram may be important for obtaining informed consent from patients with renal cell carcinoma who have indications for surgery.

Entities:  

Mesh:

Year:  2008        PMID: 19100568     DOI: 10.1016/j.juro.2008.10.017

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  [Antiandrogen strategies in prostate cancer: reconstitution of oestrogen receptor beta].

Authors:  P Thelen; A Strauss; M Stettner; S Kaulfuss; R-H Ringert; H Loertzer
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

2.  CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma.

Authors:  Walter Henriques da Costa; Rafael Malagoli Rocha; Isabela Werneck da Cunha; Francisco Paula da Fonseca; Gustavo Cardoso Guimaraes; Stenio de Cassio Zequi
Journal:  World J Urol       Date:  2011-10-04       Impact factor: 4.226

3.  Discrepancy between radiological and pathological size of renal masses.

Authors:  Nicola N Jeffery; Norbert Douek; Ding Y Guo; Manish I Patel
Journal:  BMC Urol       Date:  2011-02-22       Impact factor: 2.264

4.  Increasing trends in kidney cancer over the last 2 decades in Saudi Arabia.

Authors:  Sultan S Alkhateeb; Jawaher M Alkhateeb; Eman A Alrashidi
Journal:  Saudi Med J       Date:  2015-06       Impact factor: 1.484

5.  Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma.

Authors:  Y Ohno; J Nakashima; Y Nakagami; N Satake; T Gondo; M Ohori; T Hatano; M Tachibana
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

6.  Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.

Authors:  Yanxiang Shao; Sanchao Xiong; Guangxi Sun; Weichao Dou; Xu Hu; Weixiao Yang; Thongher Lia; Shi Deng; Qiang Wei; Hao Zeng; Xiang Li
Journal:  Cancer Med       Date:  2019-12-16       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.